Open-Label Extension Protocol to SNK01-AD01 Study

This is an open-label extension study for people who completed the SNK01-AD01 clinical trial. It allows previous participants to continue receiving the study treatment (SNK01, a natural killer cell therapy) and be monitored for long-term safety and benefit. **You may be eligible if...** - You previously completed participation in the SNK01-AD01 clinical trial - You have a reliable caregiver or study partner (such as a family member) who can attend visits and provide information about your daily functioning - You and/or your caregiver are willing and able to give written consent **You may NOT be eligible if...** - Your doctor has safety concerns about you continuing the study treatment - You did not complete the prior SNK01-AD01 study Talk to your doctor to see if this trial is right for you.